Abstract
AbstractRacial/ethnic disparities in chronic kidney disease have been well established. African Americans experience faster progression to end‐stage kidney disease and a higher prevalence of kidney‐related diseases due to social determinants of health and systemic racism. As the most accessible health care professionals, pharmacists have a responsibility to diminish racial health disparities by putting efforts into leading diversity initiatives, committees, task forces, and community outreach events. To effectively engage African American communities, pharmacists must first understand the historical context of distrust in health care, kidney‐related health and medication‐related disparities experienced by African Americans, and how socioeconomic deprivation impacts the progression of kidney disease. In this article, we review available literature pertaining to these topics and give suggestions on what pharmacists can do to help reduce health care disparities in African Americans with kidney disease and to build trust with individuals and their communities to improve their health care outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
